Targeting vasculature to reduce fetal growth restriction associated bronchopulmonary dysplasia

Respirology. 2022 Nov;27(11):920-922. doi: 10.1111/resp.14365. Epub 2022 Sep 7.

Authors

Arvind Sehgal^{1

2}, Beth J Allison^{3

4}

Affiliations

¹ Monash Newborn, Monash Children's Hospital, Clayton, Victoria, Australia.
² Department of Pediatrics, Monash University, Clayton, Victoria, Australia.
³ The Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
⁴ Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia.

No abstract available

Keywords: angiotensin converting enzyme; bronchopulmonary dysplasia; reactive oxygen species.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Bronchopulmonary Dysplasia*
Female
Fetal Growth Retardation
Humans
Infant, Newborn